
newscientist.com
Personalised cancer vaccine expected to be approved next year | New Scientist
A bespoke vaccine that is tailored to target an individual's unique skin cancer reduced rates of recurrence or death in a late-stage trial, making an approval expected
This site doesn’t allow embedding inside another page — open it in a new tab. Your Weird rating still works from the top bar.
Open source